The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease
Open accessAbstract
BACKGROUND AND AIMS: The intestinal microbiota play a pivotal role in the inflammation associated with Crohn's disease through their interaction with the mucosal immune system. Some bifidobacteria species are immunoregulatory and induce increased dendritic cell interleukin 10 (IL-10) release in vitro. Fructo-oligosaccharides (FOS) increase faecal and mucosal bifidobacteria in healthy volunteers. The aim of this study was to assess the effect of FOS administration on disease activity, bifidobacteria concentrations, and mucosal dendritic cell function in patients with moderately active Crohn's disease. PATIENTS AND METHODS: Ten patients with active ileocolonic Crohn's disease received 15 g of FOS for three weeks. Disease activity was measured using the Harvey Bradshaw index. Faecal and mucosal bifidobacteria were quantified by fluorescence in situ hybridisation, and mucosal dendritic cell IL-10 and Toll-like receptor (TLR) expression were assessed by flow cytometry of dissociated rectal biopsies. RESULTS: FOS induced a significant reduction in the Harvey Bradshaw index from 9.8 (SD 3.1) to 6.9 (3.4) (p<0.01). There was a significant increase in faecal bifidobacteria concentration from 8.8 (0.9) log(10) to 9.4 (0.9) log(10) cells/g dry faeces (p<0.001). The percentage of IL-10 positive dendritic cells increased from 30 (12)% to 53 (10)% (p=0.06). Finally, the percentage of dendritic cells expressing TLR2 and TLR4 increased from 1.7 (1.7)% to 36.8 (15.9)% (p=0.08) and from 3.6 (3.6)% to 75.4 (3.4)% (p<0.001), respectively. CONCLUSIONS: FOS supplementation increases faecal bifidobacteria concentrations and modifies mucosal dendritic cell function. This novel therapeutic strategy appears to decrease Crohn's disease activity in a small open label trial and therefore warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an open label trial of fructo-oligosaccharide in CD showed promise,79”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [79]
In the citing paper
“Additionally, prebiotic use has been shown to improve mucosal dendritic cell function associated with TLR2 activity [62], and increase the expression of glucagon-like peptide 2, associated with GI barrier regulation [59].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Amann, R., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,049
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,974
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,529
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Mucosal flora in inflammatory bowel disease
Swidsinski, A. V., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V. A., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,344
Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & SCHLEIFER, K. H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,176
Research works printed but not linked: 1
- Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4 beta7 integrin. Eur J Immunol 2002;32:1445-54.
Cited by
Sorted by citations
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
“…no clinically relevant evidence base for the use of probiotics in CD and in terms of prebiotics, although an open label trial of fructo-oligosacchar-ide in CD showed promise, 79 and a subsequent randomised placebo-controlled trial of fructo-oligosaccharide did not support any clinical bene fi t. 80”
BackgroundPrebiotic effects: metabolic and health benefits
Roberfroid, M. B., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R. A., Rowland, I. R., Wolvers, D. A. W., Watzl, B., Szajewska, H., Stahl, B., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003363 · Cited by 2,170
Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications
Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S. J., Berenjian, A., & Ghasemi, Y. (2019) · Foods · doi:10.3390/foods8030092 · Cited by 1,848
Probiotics, prebiotics and synbiotics- a review
Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1921-1 · Cited by 1,350
Dietary fibre in gastrointestinal health and disease
Gill, S. K., Rossi, M., Bajka, B., & Whelan, K. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00375-4 · Cited by 979
Inulin: Properties, health benefits and food applications
Shoaib, M., Shehzad, A., Mukama, O., Rakha, A., Raza, H., Sharif, H. R., Shakeel, A., Ansari, A., & Niazi, S. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.04.020 · Cited by 869
Dietary prebiotics: current status and new definition
Gibson, G. R., Scott, K. P., Rastall, R. A., Tuohy, K. M., Hotchkiss, A. T., Dubert‐Ferrandon, A., Gareau, M. G., Murphy, E. F., Saulnier, D. M. A., Loh, G., et al. (2010) · Food Science & Technology Bulletin Functional Foods · doi:10.1616/1476-2137.15880 · Cited by 820
Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics
Macfarlane, G. T., Steed, H., & Macfarlane, S. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03520.x · Cited by 785
Interactions of gut microbiota with functional food components and nutraceuticals
Laparra, J. M., & Sanz, Y. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.001 · Cited by 684
Review article: prebiotics in the gastrointestinal tract
Macfarlane, S., Macfarlane, G. T., & Cummings, J. H. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03042.x · Cited by 624
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. Q. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 643
Bioactivities, isolation and purification methods of polysaccharides from natural products: A review
Shi, L. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.06.100 · Cited by 563
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 571
Preidis, G. A., & Versalovic, J. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.072 · Cited by 494
From Structure to Function: the Ecology of Host-Associated Microbial Communities
Robinson, C. J., Bohannan, B. J. M., & Young, V. B. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00014-10 · Cited by 473
The Gut Microbiota in Immune-Mediated Inflammatory Diseases
Forbes, J. D., Domselaar, G. V., & Bernstein, C. N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01081 · Cited by 444
Phytochemicals for Health, the Role of Pulses
Rochfort, S. J., & Panozzo, J. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071704w · Cited by 383
Hold, G. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1192 · Cited by 365
Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Hart, A. L., Kamm, M. A., Sanderson, J. D., Knight, S. C., Forbes, A., et al. (2011) · Gut · doi:10.1136/gut.2010.232025 · Cited by 361
Self-citationEmergent Sources of Prebiotics: Seaweeds and Microalgae
De Jesus Raposo, M., De Morais, A., & De Morais, R. (2016) · Marine Drugs · doi:10.3390/md14020027 · Cited by 331
Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex
Rizzetto, L., Fava, F., Tuohy, K. M., & Selmi, C. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.05.008 · Cited by 331
Gearry, R. B., Irving, P. M., Barrett, J. S., Nathan, D. M., Shepherd, S. J., & Gibson, P. R. (2008) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2008.09.004 · Cited by 323
Inulin-type prebiotics--a review: part 1.
Kelly, G. S. (2008) · PubMed · Cited by 320
Wilson, B., & Whelan, K. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13700 · Cited by 341
Intestinal microbiota in inflammatory bowel disease: Friend of foe?
Fava, F. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.557 · Cited by 297
Functional Oligosaccharides: Application and Manufacture
Rastall, R. A. (2010) · Annual Review of Food Science and Technology · doi:10.1146/annurev.food.080708.100746 · Cited by 277
Microbiota medicine: towards clinical revolution
Gebrayel, P., Nicco, C., Khodor, S. A., Biliński, J., Caselli, E., Comelli, E. M., Egert, M., Giaroni, C., Karpiński, T. M. M., Łoniewski, I., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03296-9 · Cited by 307
Mechanisms of Action of Prebiotics and Their Effects on Gastro-Intestinal Disorders in Adults
Guarino, M. P. L., Altomare, A., Emerenziani, S., Rosa, C. D., Ribolsi, M., Balestrieri, P., Iovino, P., Rocchi, G., & Cicala, M. (2020) · Nutrients · doi:10.3390/nu12041037 · Cited by 297
Prebiotics, immune function, infection and inflammation: a review of the evidence
Lomax, A. R., & Calder, P. C. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508055608 · Cited by 257
Review article: fructose malabsorption and the bigger picture
GIBSON, P. R., Newnham, E., Barrett, J. S., Shepherd, S., & Muir, J. G. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03186.x · Cited by 256
Steed, H., Macfarlane, G. T., Blackett, K. L., Bahrami, B., Reynolds, N., Walsh, S., Cummings, J. H., & Macfarlane, S. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04417.x · Cited by 256
Inulin and Oligofructose: Review of Experimental Data on Immune Modulation
Seifert, S., & Watzl, B. (2007) · Journal of Nutrition · doi:10.1093/jn/137.11.2563s · Cited by 229
Role of the enteric microbiota in intestinal homeostasis and inflammation
Koboziev, I., Webb, C. R., Furr, K. L., & Grisham, M. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.008 · Cited by 235
Hedin, C. R. H., Whelan, K., & Lindsay, J. O. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005563 · Cited by 211
Self-citationHalmos, E. P., Christophersen, C. T., Bird, A. R., Shepherd, S., Muir, J. G., & Gibson, P. R. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.22 · Cited by 212
Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
Scaldaferri, F., Gerardi, V., Lopetuso, L. R., Zompo, F. D., Mangiola, F., Boškoski, I., Bruno, G., Petito, V., Laterza, L., Cammarota, G., et al. (2013) · BioMed Research International · doi:10.1155/2013/435268 · Cited by 207
Immune Modulation by Different Types of β2→1-Fructans Is Toll-Like Receptor Dependent
Vogt, L., Ramasamy, U. S., Meyer, D., Pullens, G., Venema, K., Faas, M. M., Schols, H. A., & de Vos, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068367 · Cited by 200
Immunological properties of inulin-type fructans
Vogt, L., Meyer, D., Pullens, G., Faas, M., Smelt, M., Venema, K., Ramasamy, U., Schols, H. A., & De Vos, P. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.656772 · Cited by 195
The intestinal microbiota in inflammatory bowel disease
Becker, C., Neurath, M. F., & Wirtz, S. (2015) · ILAR Journal · doi:10.1093/ilar/ilv030 · Cited by 185
Wasilewski, A., Zielińska, M., Storr, M., & Fichna, J. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000364 · Cited by 195
Prebiotics in Chronic Intestinal Inflammation
Langen, M. L.-V., & Dieleman, L. A. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20737 · Cited by 183
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., & Currò, D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.006 · Cited by 184
Abautret-Daly, Á., Dempsey, E., Parra‐Blanco, A., Medina, C., & Harkin, A. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.3 · Cited by 186
Failure of Synbiotic 2000 to Prevent Postoperative Recurrence of Crohn’s Disease
Chermesh, I., Tamir, A., Reshef, R., Chowers, Y., Suissa, A., Katz, D., Gelber, M., Halpern, Z., Bengmark, S., & Eliakim, R. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9549-7 · Cited by 178
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease
Orel, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11505 · Cited by 177
Walker, W. A. (2017) · Pediatric Research · doi:10.1038/pr.2017.111 · Cited by 174
Parkes, G. C., Brostoff, J., Whelan, K., & Sanderson, J. D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01869.x · Cited by 167
Zenhom, M., Hyder, A., de Vrese, M., Heller, K. J., Roeder, T., & Schrezenmeir, J. (2011) · Journal of Nutrition · doi:10.3945/jn.110.136176 · Cited by 174
Celiberto, L. S., Graef, F. A., Healey, G. R., Bosman, E. S., Jacobson, K., Sly, L. M., & Vallance, B. A. (2018) · Immunology · doi:10.1111/imm.12939 · Cited by 167
Fructo-oligosaccharides: Production, Purification and Potential Applications
Bali, V., Panesar, P. S., Bera, M. B., & Panesar, R. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.694084 · Cited by 162
Probiotics and prebiotics in chronic inflammatory bowel diseases
Ewaschuk, J. B. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i37.5941 · Cited by 159
Inulin: A novel and stretchy polysaccharide tool for biomedical and nutritional applications
Gupta, N., Jangid, A. K., Pooja, D., & Kulhari, H. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.03.188 · Cited by 151
Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’
Damaskos, D., & Kolios, G. C. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03096.x · Cited by 151
Kaji, I., Karaki, S.-I., Tanaka, R., & Kuwahara, A. (2010) · Journal of Molecular Histology · doi:10.1007/s10735-010-9304-4 · Cited by 155
Ng, S. C., Plamondon, S., Kamm, M. A., Hart, A. L., Al-Hassi, H. O., Guenther, T., Stagg, A. J., & Knight, S. C. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21222 · Cited by 147
Impact of prebiotics on immune response: from the bench to the clinic
Pujari, R., & Banerjee, G. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12409 · Cited by 154
Paineau, D., Payen, F., Panserieu, S., Coulombier, G., Sobaszek, A., Lartigau, I., Brabet, M., Galmiche, J.-P., Tripodi, D., Sacher-Huvelin, S., et al. (2008) · British Journal of Nutrition · doi:10.1017/s000711450779894x · Cited by 142
Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications
Potrykus, M., Czaja-Stolc, S., Stankiewicz, M., Kaska, Ł., & Małgorzewicz, S. (2021) · Nutrients · doi:10.3390/nu13113839 · Cited by 152
The Role of Diet and Gut Microbiota in Regulating Gastrointestinal and Inflammatory Disease
Gill, P. A., Inniss, S., Kumagai, T., Rahman, F. Z., & Smith, A. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.866059 · Cited by 164
Torres, J., Ellul, P., Langhorst, J., Mikocka‐Walus, A. A., Acosta, M. B., Basnayake, C., Ding, N. S., Gilardi, D., Katsanos, K. H., Moser, G., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz051 · Cited by 143
Praveen, M. A., Parvathy, K. R. K., Balasubramanian, P., & Jayabalan, R. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.08.011 · Cited by 140
Microbiota‐dependent and ‐independent effects of dietary fibre on human health
Cai, Y., Folkerts, J., Folkerts, G., Maurer, M., & Braber, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14871 · Cited by 142
Vitetta, L., Vitetta, G., & Hall, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02240 · Cited by 137
Significance of Inulin Fructans in the Human Diet
Schaafsma, G., & Slavin, J. L. (2014) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12119 · Cited by 139
Early Development of the Gut Microbiome and Immune-Mediated Childhood Disorders
Li, M., Wang, M., & Donovan, S. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0033-1361825 · Cited by 131
Roller, M., Clune, Y., Collins, K., Rechkemmer, G., & Watzl, B. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507450292 · Cited by 125
Rodríguez‐Cabezas, M. E., Camuesco, D., Arribas, B., Garrido‐Mesa, N., Comalada, M., Bailón, E., Cueto-Sola, M., Utrilla, P., Guerra-Hernández, E. J., Pérez-Roca, C., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.05.005 · Cited by 124
Review article: diet and inflammatory bowel disease – epidemiology and treatment
Yamamoto, T., Nakahigashi, M., & Saniabadi, A. R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04035.x · Cited by 123
Role of inulin as prebiotics on inflammatory bowel disease
Akram, W., Garud, N., & Joshi, R. (2019) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2019.01000 · Cited by 123
Ng, S. C., Benjamin, J. L., McCarthy, N. E., Hedin, C. R. H., Koutsoumpas, A. L., Plamondon, S., Price, C. L., Hart, A. L., Kamm, M. A., Forbes, A., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21590 · Cited by 131
Self-citationZhang, N., Jin, M., Wang, K., Zhang, Z., Shah, N. P., & Wei, H. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.119043 · Cited by 126
Use of the low‐FODMAP diet in inflammatory bowel disease
Gibson, P. R. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13695 · Cited by 118
Review article: FODMAPS, prebiotics and gut health‐the FODMAP hypothesis revisited
Gibson, P. R., Halmos, E. P., & Muir, J. G. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15818 · Cited by 119
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease
Wong, C., Harris, P., & Ferguson, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060919 · Cited by 116
Khor, B., Snow, M., Herrman, E., Ray, N., Mansukhani, K., Patel, K. A., Said-Al-Naief, N. A. H., Maier, T., & Machida, C. A. (2021) · Microorganisms · doi:10.3390/microorganisms9030496 · Cited by 123
Review article: evidence‐based dietary advice for patients with inflammatory bowel disease
Richman, E., & Rhodes, J. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12500 · Cited by 115
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future
Andermann, T. M., Peled, J. U., Ho, C. M., Reddy, P. R., Riches, M., Storb, R. F., Teshima, T., van den Brink, M. R. M., Alousi, A. M., Balderman, S., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.02.009 · Cited by 113
Parkes, G. C., Sanderson, J. D., & Whelan, K. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70059-3 · Cited by 115
Preter, V. D., Joossens, M., Ballet, V., Shkedy, Z., Rutgeerts, P. J., Vermeire, S., & Verbeke, K. (2013) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2012.24 · Cited by 109
Inulin and Oligofructose in Chronic Inflammatory Bowel Disease
Leenen, C. H., & Dieleman, L. A. (2007) · Journal of Nutrition · doi:10.1093/jn/137.11.2572s · Cited by 107
How can probiotics and prebiotics impact mucosal immunity?
O'Flaherty, S., Saulnier, D., Pot, B., & Versalovic, J. (2010) · Gut Microbes · doi:10.4161/gmic.1.5.12924 · Cited by 103
Roberts, J., Suckling, C., Peedle, G., Murphy, J., Dawkins, T., & Roberts, M. (2016) · Nutrients · doi:10.3390/nu8110733 · Cited by 99
“Additionally, prebiotic use has been shown to improve mucosal dendritic cell function associated with TLR2 activity [62], and increase the expression of glucagon-like peptide 2, associated with GI barrier regulation [59].”
BackgroundIntestinal bacteria and inflammatory bowel disease
Macfarlane, S., Steed, H., & Macfarlane, G. T. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360802485792 · Cited by 99
Bosscher, D., Breynaert, A., Pieters, L. A. C., & Hermans, N. (2009) · PubMed · Cited by 98
Perioperative dietary therapy in inflammatory bowel disease.
Adamina, M., Gerasimidis, K., Sigall-Boneh, R., Zmora, O., van Overstraeten, A. D. B., Campmans-Kuijpers, M., Ellul, P., Katsanos, K., Kotze, P., Noor, N., et al. (2019) · Journal of Crohn's & Colitis · doi:10.1093/ecco-jcc/jjz160 · Cited by 86
Landy, J., Walker, A. W., Li, J. V., Al-Hassi, H. O., Ronde, E., English, N. R., Mann, E. R., Bernardo, D., McLaughlin, S. D., Parkhill, J., et al. (2015) · Scientific Reports · doi:10.1038/srep12955 · Cited by 93
Interactions between Host PPARs and Gut Microbiota in Health and Disease
Hasan, A. U., Rahman, A., & Kobori, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020387 · Cited by 93
Health-promoting approaches of the use of chia seeds
Motyka, S., Skała, E., Ekiert, H., & Szopa, A. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105480 · Cited by 90
Asakura, H., Suzuki, K., Kitahora, T., & Morizane, T. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05681.x · Cited by 89
Kato, T., Fukuda, S., Fujiwara, A., Suda, W., Hattori, M., Kikuchi, J., & Ohno, H. (2014) · DNA Research · doi:10.1093/dnares/dsu013 · Cited by 88
In vitro assessment of agave fructans (Agave salmiana) as prebiotics and immune system activators
Moreno-Vilet, L., García-Hernández, M. H., Portales, R. E. D., Corral-Fernández, N. E., Cortez-Espinosa, N., Ruiz‐Cabrera, M. A., & Portales‐Pérez, D. P. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.10.039 · Cited by 88
Goji Berry Modulates Gut Microbiota and Alleviates Colitis in IL‐10‐Deficient Mice
Kang, Y., Yang, G., Zhang, S., Ross, C. F., & Zhu, M. J. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800535 · Cited by 88
Carbohydrate catabolic diversity of bifidobacteria and lactobacilli of human origin
McLaughlin, H. P., Motherway, M. O., Lakshminarayanan, B., Stanton, C., Ross, R. P., Brulc, J. M., Menon, R. S., O’Toole, P. W., & van Sinderen, D. (2015) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2015.03.008 · Cited by 86
Costa, G. T., Vasconcelos, Q. D. J. S., & Aragão, G. F. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab115 · Cited by 86
van der Aa, L. B., Heymans, H. S. A., van Aalderen, W. M. C., & Sprikkelman, A. B. (2009) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2009.00915.x · Cited by 84
Sinagra, E., Utzeri, E., Morreale, G. C., Fabbri, C., Pace, F., & Anderloni, A. A. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i6.1013 · Cited by 85
Vandeputte, D., & Joossens, M. (2020) · Microorganisms · doi:10.3390/microorganisms8111638 · Cited by 86
Prebiotics to Fight Diseases: Reality or Fiction?
Bartolomeo, F. D., Startek, J. B., & den Ende, W. V. (2012) · Phytotherapy Research · doi:10.1002/ptr.4901 · Cited by 85
Liao, M., Zhang, Y., Qiu, Y., Wu, Z., Zhong, Z., Zeng, X., Zeng, Y., Xiong, L., Wen, Y., & Liu, R. (2021) · Food & Function · doi:10.1039/d1fo01147b · Cited by 79
Metadata
- Authors
- Lindsay, J. O.
- Affiliations
- Royal London Hospital (GB)
- Corresponding author
- Lindsay, J O
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2006-03-01
- Volume
- 55
- Issue
- 3
- Pages
- 348-355
- ISSN
- 0017-5749 (ISSN-L)
- PMC
- PMC1856087
- OpenAlex
- W2164571061
- Cited by
- 471
- References
- 55
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 33 · 2023: 19 · 2022: 35 · 2021: 26 · 2020: 32 · 2019: 20 · 2018: 21 · 2017: 18 · 2016: 21 · 2015: 18 · 2014: 26 · 2013: 21 · 2012: 22
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- fructooligosaccharides, Crohn's disease, Bifidobacterium, dendritic cells, IL-10, TLR2, TLR4, gut microbiota, mucosal immunity, disease activity, prebiotics, rectal mucosa
- MeSH terms
- Adult, Bifidobacterium, Crohn Disease, Dendritic Cells, Feces, Female, Humans, Intestinal Mucosa, Male, Middle Aged, Oligosaccharides, Patient Compliance, Severity of Illness Index, Immunity, Mucosal, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
